← Back to Search

Compression Device

Nasal Compression Device for Nosebleeds

N/A
Recruiting
Research Sponsored by NasaClip
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presenting with anterior epistaxis determined as someone with venous bleeding that can be controlled with external compression.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up checked at 10 min intervals for a total of 3 intervals (30 min).
Awards & highlights

Study Summary

This trial will compare a nasal compression device to manual compression to stop nosebleeds. Participants will evaluate their experience to see which works best.

Who is the study for?
This trial is for adults over 18 in good health who have anterior nosebleeds that can be stopped with pressure. They must be willing to follow the study rules and stay for the whole study. It's not for those allergic to NasaClip or oxymetazoline, pregnant, unable to consent, prisoners, or with uncontrolled high blood pressure, heart disease, thyroid issues, diabetes, prostate problems or on MAO inhibitors.Check my eligibility
What is being tested?
The study compares a nasal compression device against standard manual compression to stop anterior nosebleeds. Participants will either use the new device or receive routine care and then answer questions about their satisfaction and comfort during treatment.See study design
What are the potential side effects?
While specific side effects are not listed for this trial of a nasal compression device versus manual compression; discomfort at the site of application may occur. Any additional side effects would likely relate to individual sensitivity to the materials used in the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have nosebleeds from the front of my nose that stop when pressure is applied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~checked at 10 min intervals for a total of 3 intervals (30 min).
This trial's timeline: 3 weeks for screening, Varies for treatment, and checked at 10 min intervals for a total of 3 intervals (30 min). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
- Change over time from full epistaxis to cessation.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Nasal Compression DeviceExperimental Treatment1 Intervention
Participants assigned to the nasal compression device arm will be provided with the device package which will include the compression device, nasal sponges, and +/- oxymetazoline nasal spray to apply to the sponges as well as written/graphical assembly and application instructions. Participants will then assemble and apply the device themselves under the supervision of a trained medical provider.
Group II: Standard of CareActive Control1 Intervention
Participants assigned to the standard of care arm will be guided through clearing out clots in the nose (if using oxymetazoline), correct head positioning and how to appropriately hold nasal pressure and +/- oxymetazoline applied by a trained medical provider. No packing material will be inserted into the nares and only external pressure will be applied.

Find a Location

Who is running the clinical trial?

Emergency Medical Innovations, LLCUNKNOWN
NasaClipLead Sponsor

Media Library

Nasal Compression Device (Compression Device) Clinical Trial Eligibility Overview. Trial Name: NCT05789264 — N/A
Nosebleed Research Study Groups: Nasal Compression Device, Standard of Care
Nosebleed Clinical Trial 2023: Nasal Compression Device Highlights & Side Effects. Trial Name: NCT05789264 — N/A
Nasal Compression Device (Compression Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05789264 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively seeking to expand its participants?

"According to clinicaltrials.gov, this medical experimentation is currently recruiting patients and has been doing so since March 1st 2023 (most recently edited on the 15th of that same month)."

Answered by AI

What is the current selection quota for this trial?

"Affirmative. According to clinicaltrials.gov, this trial is currently enrolling patients that meet their requirements. Initially posted on March 1st 2023 with the most recent update occurring on March 15th 2023, 40 individuals are being sought by a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
Next Level Urgent Care
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Nasal Compression Device Study for Epistaxis
2023. "Nasal Compression Device Study for Epistaxis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05789264.
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top